The role of remineralizing and anticaries agents in caries management.
The role of remineralizing and anticaries agents in caries management.
复制标题
DOI：
10.1177/0022034512452885
复制
发表时间：
2012-09-01
影响因子：
--
通讯作者：
Domejean, S
中科院分区：
文献类型：
--
作者：
Featherstone, J D;Domejean, S
第一届ICNARA会议（新型抗牙剂和再矿化剂国际会议）于2008年1月在智利举行，会议记录发表在《牙科研究进展》（2009年第21卷）上。这一期《进展》总结了龋齿管理的科学现状，并为未来的两个关键组成部分，即抗菌剂和再矿化剂制定了研究议程。第二次会议（ICNARA 2, 2012年1月）为研究和临床实践提供了最新的科学和新的方向。在过去的十年中，世界各地都在重新努力建立行之有效的龋齿风险评估方法，并为改进基于风险水平的龋齿管理方法提供指导。现在有了基于证据的龋齿风险评估工具。现在非常清楚，需要改进治疗方法，以减少引发龋齿过程的细菌挑战，并加强再矿化。仅靠氟化物治疗不足以控制高危人群的龋病进程。新的再矿化和抗龋产品以及新的输送系统正在开发中，ICNARA 2展示了龋齿管理的未来技术。
The first ICNARA conference (International Conference on Novel Anticaries and Remineralizing Agents) was held in Chile in January, 2008, and the proceedings were published in Advances in Dental Research (Volume 21, 2009). That issue of Advances summarized the state of the science and set a research agenda for the future for two key components of caries management, namely, antibacterial agents and remineralizing agents. The second conference (ICNARA 2, January 2012) provided an update on science and new directions for research and clinical practice. Over the past decade, renewed efforts have been made across the world to establish proven methods of caries risk assessment and to provide direction for improved methods of caries management based upon risk levels. Evidence-based caries risk assessment tools are now available. The need for improved therapy to reduce the bacterial challenge that initiates the caries process, and to enhance remineralization, is now very clear. Fluoride therapy alone is insufficient to control the caries process in high-risk individuals. New remineralizing and anticaries products and new delivery systems are in development, and ICNARA 2 presents future technology for the management of dental caries.